Llun o Orod Osanlou

Orod Osanlou

Dr

Ymlyniadau blaenorol
20212023

Allbwn ymchwil fesul blwyddyn

Proffil personol

Manylion Cyswllt

Safleoedd allanol

Local Councillor, Wirral Council

1 Tach 2021 → …

Director, North Wales Clinical Research Facility

1 Hyd 2021 → …

Lead Principal Investigator, Vaccine Trials, Public Health Wales

1 Awst 2020 → …

Consultant Physician, Clinical Pharmacology and Therapeutics, General Internal Medicine, Betsi Cadwaladr University Health Board

1 Chwef 2020 → …

Ôl bys

Ewch i ganol y pynciau ymchwil lle mae Orod Osanlou ar waith. Mae’r labelau pwnc hyn yn dod o waith y person hwn. Gyda’i gilydd maen nhw’n ffurfio ôl bys unigryw.
  • 1 Proffiliau Tebyg

Cydweithrediadau a’r prif feysydd ymchwil yn ystod y pum mlynedd ddiwethaf

Cydweithrediad allanol yn ddiweddar ar lefel gwlad/tiriogaeth. Plymiwch i mewn i'r manylion drwy glicio ar y dotiau neu
  • Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

    Heath, P. T., Galiza, E. P., Baxter, D. N., Boffito, M., Browne, D., Burns, F., Chadwick, D. R., Clark, R., Cosgrove, C. A., Galloway, J., Goodman, A. L., Heer, A., Higham, A., Iyengar, S., Jeanes, C., Kalra, P. A., Kyriakidou, C., Bradley, J. M., Munthali, C. & Minassian, A. M. & 25 eraill, McGill, F., Moore, P., Munsoor, I., Nicholls, H., Osanlou, O., Packham, J., Pretswell, C. H., San Francisco Ramos, A., Saralaya, D., Sheridan, R. P., Smith, R., Soiza, R. L., Swift, P. A., Thomson, E. C., Turner, J., Viljoen, M. E., Fries, L., Cho, I., McKnight, I., Glenn, G., Rivers, E. J., Robertson, A., Alves, K., Smith, K. & Toback, S., 1 Chwef 2023, Yn: Clinical Infectious Diseases. 76, 3, t. 398-407 10 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

    Mynediad agored
    Ffeil
    1 Wedi eu Llwytho i Lawr (Pure)
  • Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial

    Liu, X., Munro, A. P. S., Feng, S., Janani, L., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dejnirattisai, W., Dodd, K., Enever, Y., Qureshi, E., Goodman, A. L., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A. A. & Kwok, J. & 37 eraill, Libri, V., Llewelyn, M. J., McGregor, A. C., Minassian, A. M., Moore, P., Mughal, M., Mujadidi, Y. F., Holliday, K., Osanlou, O., Osanlou, R., Owens, D. R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Serafimova, T., Saralaya, D., Screaton, G. R., Sharma, S., Sheridan, R., Sturdy, A., Supasa, P., Thomson, E. C., Todd, S., Twelves, C., Read, R. C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J. S., Cornelius, V., Snape, M. D. & Faust, S. N., Meh 2022, Yn: Journal of Infection. 84, 6, t. 795-813 19 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

    Mynediad agored
    Ffeil
    58 Wedi eu Llwytho i Lawr (Pure)
  • Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

    Munro, A. P. S., Feng, S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Qureshi, E., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., Klaauw, A. A. V. D. & Kanji, N. & 344 eraill, Libri, V., Llewelyn, M. J., McGregor, A. C., Maallah, M., Minassian, A. M., Moore, P., Mughal, M., Mujadidi, Y. F., Holliday, K., Osanlou, O., Osanlou, R., Owens, D. R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Bawa, T., Saralaya, D., Sharma, S., Sheridan, R., Thomson, E. C., Todd, S., Twelves, C., Read, R. C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J. S., Snape, M. D., Liu, X., Faust, S. N., Munro, A. P. S., Feng, S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Qureshi, E., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., Klaauw, A. A. V. D., Kanji, N., Libri, V., Llewelyn, M. J., McGregor, A. C., Minassian, A. M., Moore, P., Mughal, M., Mujadidi, Y. F., Holliday, K., Osanlou, O., Osanlou, R., Owens, D. R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Bawa, T., Saralaya, D., Sharma, S., Sheridan, R., Maallah, M., Thomson, E. C., Todd, S., Twelves, C., Read, R. C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J. S., Snape, M. D., Liu, X., Faust, S. N., Riordan, A., Ustianowski, A., Rogers, C., Katechia, K., Cooper, A., Freedman, A., Hughes, R., Grundy, L., Jones, L. T., Harrison, E., Snashall, E., Mallon, L., Burton, K., Storton, K., Munusamy, M., Tandy, B., Egbo, A., Cox, S., Ahmed, N. N., Shenoy, A., Bousfield, R., Wixted, D., Gutteridge, H., Mansfield, B., Herbert, C., Murira, J., Calderwood, J., Barker, D., Brandon, J., Tulloch, H., Colquhoun, S., Thorp, H., Radford, H., Evans, J., Baker, H., Thorpe, J., Batham, S., Hailstone, J., Phillips, R., Kumar, D., Westwell, F., Sturdy, A., Barcella, L., Soussi, N., Mpelembue, M., Raj, S., Sharma, R., Corrah, T., John, L., Whittington, A., Roche, S., Wagstaff, L., Farrier, A., Bisnauthsing, K., Abeywickrama, M., Spence, N., Packham, A., Serafimova, T., Aslam, S., McGreevy, C., Borca, A., DeLosSantosDominguez, P., Palmer, E., Broadhead, S., Farooqi, S., Piper, J., Weighell, R., Pickup, L., Shamtally, D., Domingo, J., Kourampa, E., Hale, C., Gibney, J., Stackpoole, M., Rashid-Gardner, Z., Lyon, R., McDonnell, C., Cole, C., Stewart, A., McMillan, G., Savage, M., Beckett, H., Moorbey, C., Desai, A., Brown, C., Naker, K., Gokani, K., Trinham, C., Sabine, C., Moore, S., Hurdover, S., Justice, E., Stone, M., Plested, E., Silva, C. F. D., White, R., Robinson, H., Turnbull, I., Morshead, G., Drake-Brockman, R., Smith, C., Li, G., Kasanyinga, M., Clutterbuck, E. A., Bibi, S., Singh, M., Champaneri, T., Irwin, M., Khan, M., Kownacka, A., Nabunjo, M., Osuji, C., Hladkiwskyj, J., Galvin, D., Patel, G., Grierson, J., Males, S., Askoolam, K., Barry, J., Mouland, J., Longhurst, B., Moon, M., Giddins, B., Alves, C. P. D., Richmond, L., Minnis, C., Baryschpolec, S., Elliott, S., Fox, L., Graham, V., Baker, N., Godwin, K., Buttigieg, K., Knight, C., Brown, P., Lall, P., Shaik, I., Chiplin, E., Brunt, E., Leung, S., Allen, L., Thomas, S., Fraser, S., Choi, B., Gouriet, J., Perkins, J., Gowland, A., Macdonald, J., Seenan, J. P., Starinskij, I., Seaton, A., Peters, E., Singh, S., Gardside, B., Bonnaud, A., Davies, C., Gordon, E., Keenan, S., Hall, J., Wilkins, S., Tasker, S., James, R., Seath, I., Littlewood, K., Newman, J., Boubriak, I., Suggitt, D., Haydock, H., Bennett, S., Woodyatt, W., Hughes, K., Bell, J., Coughlan, T., Welsenes, D. V., Kamal, M., Cooper, C., Tunstall, S., Ronan, N., Cutts, R., Dare, T., Yim, Y. T. N., Whittley, S., Hamal, S., Ricamara, M., Adams, K., Baker, H., Driver, K., Turner, N., Rawlins, T., Roy, S., Merida-Morillas, M., Sakagami, Y., Andrews, A., Goncalvescordeiro, L., Stokes, M., Ambihapathy, W., Spencer, J., Parungao, N., Berry, L., Cullinane, J., Presland, L., Russell, A. R., Warren, S., Baker, J., Oliver, A., Buadi, A., Lee, K., Haskell, L., Romani, R., Bentley, I., Whitbred, T., Fowler, S., Gavin, J., Magee, A., Watson, T., Nightingale, K., Marius, P., Summerton, E., Locke, E., Honey, T., Lingwood, A., Haye, A. D. L., Elliott, R. S., Underwood, K., King, M., Davies-Dear, S., Horsfall, E., Chalwin, O., Burton, H., Edwards, C. J., Welham, B., Appleby, K., Dineen, E., Garrahy, S., Hall, F., Ladikou, E., Mullan, D., Hansen, D., Campbell, M., Santos, F. D., Lakeman, N., Branney, D., Vamplew, L., Hogan, A., Frankham, J., Wiselka, M., Vail, D., Wenn, V., Renals, V., Ellis, K., Lewis-Taylor, J., Habash-Bailey, H., Magan, J. & Hardy, A., 1 Awst 2022, Yn: Lancet Infectious Diseases. 22, 8, t. 1131-1141 11 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

    Mynediad agored
    Ffeil
    77 Wedi eu Llwytho i Lawr (Pure)
  • Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

    Heath, P. T., Galiza, E. P., Baxter, D. N., Boffito, M., Browne, D., Burns, F., Clark, R., Cosgrove, C., Galloway, J., Goodman, A. L., Heer, A., Higham, A., Iyengar, S., Jamal, A., Jeanes, C., Kalra, P. A., Kyriakidou, C., McAuley, D. F., Meyrick, A. & Minassian, A. M. & 24 eraill, Minton, J., Moore, P., Munsoor, I., Nicholls, H., Osanlou, O., Packham, J., Pretswell, C. H., San Francisco Ramos, A., Saralaya, D., Sheridan, R. P., Smith, R., Soiza, R. L., Swift, P. A., Thomson, E. C., Turner, J., Viljoen, M. E., Albert, G., Cho, I., Dubovsky, F., Glenn, G., Rivers, J., Robertson, A., Smith, K. & Toback, S., 23 Medi 2021, Yn: New England Journal of Medicine. 385, 13, t. 1172-1183

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid